Artificial intelligence (AI) is transforming neuro-oncology by enhancing diagnosis, prognosis, and treatment planning for gliomas. AI models outperform human evaluations in terms of accuracy and specificity, leveraging machine learning and deep learning techniques to analyze MRI scans, histopathological, and genomic data. AI also enables adaptive personalized treatment strategies, tailoring care to individual patients based on their unique characteristics. While there are challenges and limitations, including data integration, addressing disparities, and ensuring transparency and fairness, AI has the potential to revolutionize brain tumor management, leading to better patient outcomes and improved quality of life.
Source Nature
